GNC-038

· Sichuan Baili Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GNC-038, covering 2025-06-24 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL) [Phase 1, Phase 2]

See pricing